AIDS-associated cerebral toxoplasmosis: An update on diagnosis and treatment

Current Topics in Microbiology and Immunology

Volumn 219, Issue , 1996, Pages 209-222

  Ammassari, A ^a   Murri, R ^a   Cingolani, A ^a   De Luca, A ^a   Antinori, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; FOLINIC ACID; PYRIMETHAMINE; SULFADIAZINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN BIOPSY; BRAIN INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TOXOPLASMOSIS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029743155     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-51014-4_19     Document Type: Review

References (63)

1. Ammassari A, Scoppettuolo G, Mum R, et al (1995) Temporal trends of toxoplasmic encephalitis (TE) and primary central nervous system lymphoma (PCNSL) in a prospective study on brain focal lesions Fifth European Conference on Clinical Aspects and Treatment of HIV Infection. 26-29 September 1995, Copenhagen, Denmark, abstract 442
2. Anson JA, Glick RP, Reyes MR (1992) Diagnostic accuracy of AIDS-related CNS lesions. Surg Neurol 37 432-440
3. Antinori A, Murri R, Tamburrini E, De Luca A, Ortona L (1992) Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia. Lancet 340:788
4. Antinori A, Ammassari A, Murri R, Tumbarello M, Ortona L, Scerrati M, Roselli R, Cefsro GA (1993) Primary central nervous system lymphoma and brain biopsy in AIDS. Lancet 341:1411-1412
5. Antinori A, Murri R, Ammassari A, et al (1995) Aerosolized pentamidine, cotrimoxazole, and dapsone-pyrimethamine for primary prophylaxis of P. carinii pneumonia and toxoplasmic encephalitis. AIDS 12.1343-1350
6. Aurelius E, Johansson B, Skoldenberg B, Staland A, Forsgren M (1990) Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction of cerebrospinal fluid. Lancet 337:189-192
7. Bacellar H, Munoz A, Miller EN, Cohen BA, Besley D, Selnes OA, Becker JT, McArthur JC (1994) Temporal trends in the incidence of HIV-1-related neurologic diseases: multicenter AIDS cohort Study, 1985-1992. Neurology 44.1892-1900
8. Baumgartner JE, Rachlin JR, Beckstead JH, Meeker TC, Levy RM, Wara WM, Rosenblum MC (1990) Primary central nervous system lymphomas. natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 73:206-211
9. Bretagne S, Costa JM, Fleury-Feith J, et al (1995) Quantitative competitive PCR with bronchoalveolar lavage fluid for diagnosis of toxoplasmosis in AIDS patients J Clin Microbiol 33:1662-1664
10. Burg JL, Grover CM, Pouletty P, Boothroyd JC (1989) Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 27:1787-1792
11. Carr A, Tindall B, Penny R, Cooper DA (1992) Trimethoprim sulfamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. AIDS 6.165-171
12. Centers for Disease Control (1993) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41(RR17):1-19
13. Centers for Disease Control (1995) USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus a summary. MMWR 44: 1-34
14. Chappell ET, Guthrie BL, Orenstein J (1992) The role of stereotactic biopsy in the management of HIV-related focal brain lesions Neurosurgery 30.825-829
15. Cimino C, Lipton R, Williams A, Feraru E, Harris C, Hirschfeld A (1991) The evaluation of patients with human immunodeficiency virus-related disorders and brain mass lesions. Arch Intern Med 151:1381-1384
16. Cingolani A, De Luca A, Larocca LM et al (1995) EBV-DNA detection in cerebrospinal fluid for the in vivo diagnosis of AIDS-associated primary CNS lymphoma. Fifth European Conference on Clinical Aspects and Treatment of HIV Infection, 26-29 September 1995, Copenhagen, Denmark, abstract 339
17. Cinque P, Brytting M, Vago L, Castagna A, Parravicini C, Zanchetta N, d'Arminio-Monforte A, Wahren B, Lazzarin A, Linde A (1993) Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system Lancet 342:398-402
18. Cirillo S, Rosenblum ML (1991) Use of CT and MR imaging to distinguish mtracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg 73:720-724
19. Cohn JA, McKeeking A, Cohen W, Jacobs J, Holzman RS (1989) Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Am J Med 86:521-527
20. Dannemann BR, Israelski DM, Leoung GS, McGraw T, Mills J, Remington JS (1991) Toxoplasma serology, parasitemia and antigenemia in patients at risk for toxoplasmic encephalitis. AIDS 5:1363-1365
21. de Gans J, Portegies P, Reiss P, Troost D, van Gool T, Lange JM (1992) Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS. J Acquir Immune Defic Syndr 5.137-142
22. De Luca A, Antinori A, Cingolani A, et al (1995) Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 90:844-849
23. DeWit S, Katlama C, Clumeck N and the ENTA toxoplasmosis study group (1994) Tolerance of pyrimethamine-clindamycin and pyrimethamine-sulfadiazine during acute therapy of toxoplasmic encephalitis in AIDS patients in a randomized European multicentre study (ENTA 004). Fourth European Conference on Clinical Aspects and Treatment of HIV Infection, 16-18 March 1994, Milan, Italy, abstract P192
24. Dupon M, Cazenave J, Pellegrin JL Ragnaud JM. Cheyron A, Fischer I, Leng B, Lacut JY (1995) Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients. J Clin Microbiol 33:2421-2426
25. Eggers C, Gross U, Klinker H, Schaike B, Stellbrink HJ, Kunze K (1995) Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS. J Neurol 242:644-649
26. Forsyth PA, Yahalom J, DeAngelis LM (1994) Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 44:1473-1479
27. Girard PM, Landman R, Gaudebout C, Olivares R, Saimont AG, Jelazko P, Gaudebout C, Certain A, Boue F, Bouvet E, Lecompte T, Couland JP (1993) Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 328:1514-1520
28. Grant IH, Gold JWM, Rosenblum M, Niedzwiecki A, Armstrong D (1990) Toxoplasma gondii serology in HIV-infected patients: the development of cerebral nervous system toxoplasmosis in AIDS. AIDS 4:519-521
29. Grover CM, Thuiliez P, Remington S, Boothroyd JC (1990) Rapid prenatal diagnosis of congenital toxoplasmosis from amniotic fluid by polymerase chain reaction. J Clin Microbiol 28.2297-2301
30. Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, Frame PT, Holmes M, Waskin H, Fass RJ, et al (1992) A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 327:1842-1848
31. Haverkos HW (1987) Assessment of therapy for toxoplasmic encephalitis. Am J Med 82:907-914
32. Heald A, Flepp M, Chave J-P, Malinverni R, Ruttimann S, Gabriel V, Renold C, Sugar A, Hirschel B (1991) Treatment of cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. Ann Intern Med 115:760-763
33. Iacoangeli M, Roselli R, Antinori A, Ammassari A, Murri R, Pompucci A, Scerrati M (1994) Experience with brain biopsy in acquired immune deficiency syndrome-related focal lesions of the central nervous system Br J Surg 81.1508-1511
34. Israelski DM, Chmiel JS, Poggensee L, Phair JP, Remington JS (1993) Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis J Acquir Immune Defic Syndr 6:414-418
35. Jacobson MA, Besch CL, Child C, Hafner R, Matts JP, Muth K, Wentworth DN, Neaton JD, Abrams D, Rimland D (1994) Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. J Infect Dis 169:384-394
36. Katiama C, De Wit S, Guichard A, Van Pottelsberghe C, Van Glabeke M, Clumeck N, and the ENTA Toxoplamosis Study Group (1994) Efficacy of pyrimethamine-clindamycin (P-C) for the long term suppressive therapy of toxoplasmosis encephalitis (TE) in AIDS patients (ENTA 04 study). Fourth European Conference on Clinical Aspects and Treatment of HIV Infection, 16-18 March 1994, Milan, Italy, abstract 043
37. Kovacs JA (1992) Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. Lancet 340 637-638
38. Lebech M, Lebech AM, Nelsing S, Vuust C, Mathiesen L, Petersen E (1992) Detection of Toxoplasma gondii-DNA by polymerase chain reaction in cerebrospinal fluid from AIDS patients with cerebral toxoplasmosis J Infect Dis 165:982-983
39. Leport C, Raffi F, Matheron S, Katlama C, Regnier B, Saimot AG, Marche C, Vedrenne C, Vilde JL (1988) Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Am J Med 84:94-100
40. Leport C, Tournerie C, Raguin G, Fernandez-Martin J, Nijongabo T, Vilde JL (1991) Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis. Eur J Clin Microbiol Infect Dis 10.191-193
41. Levy RM, Russell E, Yungbluth M, Hidvegi DF, Brody BA, Dal-Canto MC (1992) The efficacy of image-guided stereotactic brain biopsy in neurologecally symptomatic acquired immunodeficiency syndrome patients Neurosurgery 30:186-190
42. Luft BJ, Remington JS (1988) Toxoplasmic encephalitis. J Infect Dis 157:1-6
43. Luft BJ, Hafner R, Korzun AH, Leport C, Antoniskis D, Bosler EM, Bourland DD, Uttamchandani R, Fuhrer J, Jacobson J, et al (1993) Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 329:995-1000
44. Morgello S, Petite CK, Mouradian JA (1990) Central nervous system lymphoma in the acquired immunodeficiency syndrome Clin Neuropathol 9:205-215
45. Morlat P, Chene G, Leport C, Rousseau F, Luft B, Aubertin J, Hafner R, Salamon R, Vilde JL (1993) Prevention primaire de la toxoplasmose cerebrale chez le sujet infecté par le VIH:resultats d'un essai randomisé en double insu, pyrimethamine versus placebo Rev Med Interne 14:1002
46. Mouthon B, Katlama C, Caumes E, Bricaire F, Gentilini M (1994) Atovaquone (ATQ) as long-term suppressive therapy in toxoplasmosis Fourth European Conference on Clinical aspects and Treatment of HIV Infection, 16-18 March 1994, Milan, Italy, abstract 043
47. Navia BA, Petito CK, Gold JWM, Cho ES, Jordan BD, Price RW (1986) Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome:clinical and neuropathological findings in 27 patients. Ann Neurol 19:224-238
48. Novati R, Castagna A, Morsica G, Vago L, Tambussi G, Ghezzi S, Gervasoni C, Bisson C, d'Arminio-Monforte A, Lazzarin A (1994) Polymerase chain reaction for Toxoplasma gondii DNA in cerebrospinal fluid of AIDS patients with focat brain lesions AIDS 8:1691-1694
49. Oksenhendler E, Charreau I, Tournerie C, Azihary M, Carbon C, Aboulker JP (1994) Toxoplasma gondii infection in advanced HIV infection. AIDS 8.483-487
50. Opravil M, Heald A, Lazzarin A, Heald A, Ruttimann S, Iten A, Furrer H, Oertle D, Praz G, Vuitton DA et al (1995) Dapsone-pyrimethamine versus aerosolized pentamidine for combined prophylaxis of PCP and toxoplasmic encephalitis Clin Infect Dis 20:531-541
51. Pedrol E, Gonzalez-Clemente JM, Gatell JM, Mallolas J, Miro JM, Grans F, Alvarez R, Mercorder JM, Berenguer J, Jimenez de Anta MT et al (1990) Central nervous system toxoplasmosis in AIDS patients. efficacy of an intermittent maintenance therapy. AIDS 4.511-517
52. Pell MF, Thomas DGT, Whittle IR (1991) Stereotactic biopsy of cerebral lesions in patients with AIDS. Br J Neurosurg 5:585-589
53. Podzamczer D, Miro JM, Bolao F, et al (1995) Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS Ann Intern Med 123.175-180
54. Porter SB, Sande MA (1992) Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 327:1643-1648
55. Ruf B, Schürmann D, Bergmann F, Schuler-Maué W, Grünewald T, Gottschalk HJ, Witt H, Pohle HD (1993) Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients. Eur J Clin Microbiol Infect Dis 12 325-329
56. Schoondermark-van de Ven E, Galama J, Kraaijeveld C, van Druten J, Meuwissen J, Meichers W (1993) Value of polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. Clin Infect Dis 16:661-666
57. Steinmetz H, Arendt G, Hefter H, Neuen-Jacob E, Dorries K, Aulich A, Kahn T (1995) Focal brain lesions in patients with AIDS aetiologies and corresponding radiological patterns in a prospective study J Neurol 242:69-74
58. Tenant-Flowers M, Boyle MJ, Carey D, Marriott DJ, Harkness JL, Penny R, Cooper DA (1991) Sulfadiazine desensitization in patients with AIDS and cerebral toxoplasmosis. 5:311-315
59. Torres R, Weinberg W, Stansell J, et al (1993) Multicenter clinical trial of atovaquone (ATQ) for salvage treatment and suppression of toxoplasmic encephalitis (TE) Ninth International Conference on AIDS, 6-11 June 1993, Berlin, Germany, abstract PO-B10-1453
60. Wallace MR, Rossetti RJ, Olson PE (1993) Cats and toxoplasmosis risk in HIV-infected adults JAMA 269:76-77
61. Weiss LM, Udem SA, Salgo M, Tanowitz HB, Wittner M (1991) Sensitive and specific detection of Toxoplasma DNA in an experimental murine model: use of T gondii-specific cDNA and the polymerase chain reaction. J Infect Dis 193: 180-186
62. Zangerle R, Allerberger F, Pohl P, Fritsch P, Dierich MP (1991) High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii. Med Microbiol Immunol 180:59-66
63. Zimmer C, Marzheuser S. Part S (1992) Stereotactic brain biopsy in AIDS. J Neurol 239.394-400